News

A new cardiac treatment facility that couples the benefits of interventional cardiology with cardiothoracic surgery for critically ill newborns, children and adults has opened at Rush University...
Toshiba America Medical Systems’ Infinix Hybrid cardiovascular X-ray imaging system will be featured in three live cases during the International Symposium on the Hybrid Approach to Congenital Heart...

June 8, 2008 - A new study about how shear stress improves adult stem cell attachment to vascular surfaces moves researchers closer to the development of a unique tissue-engineered stem cell...

April 22, 2008 - A new type of medication based on raising high-density lipoproteins (HDL), can lead to an improvement in the aortic valve narrowing, reported study results published on-line in...

April 15, 2008 - Researchers at the University of North Carolina at Chapel Hill's School of Medicine have shown some heart cells in response to one signal will act, while others lie in wait,...

April 15, 2008 - Physician scientists at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital have begun the world's first clinical trial to treat heart attack patients with a special...

April 14, 2008 - ESTECH will showcase its new CG LiV Kits, designed to enable mitral and aortic valve procedures, at the American Association for Thoracic Surgery 88th Annual Meeting in San Diego...

March 5, 2008 - Edwards Lifesciences Corp. reported that the first three human implants of the next-generation Edwards transcatheter aortic heart valve were performed at St. Paul's Hospital in...

February 11, 2008 – A new minimally invasive vascular occlusion device designed to close a patent ductus arteriosus (PDA) received European CE Mark approval.

February 8, 2008 - CryoLife Inc. received 510(k) clearance from the FDA for its CryoValve SG pulmonary human heart valve processed with the company’s proprietary SynerGraft technology, providing a...

February 7, 2008 - A Northwestern University Feinberg School of Medicine researcher has launched the first U.S. trial in which a purified form of subjects' own adult stem cells is transplanted...

January 30, 2008 - Aporo Biomedical signed an exclusive global licensing agreement with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP), enabling Aporo to offer...